ValuEngine Upgrades Prestige Consumer Healthcare (PBH) to Hold

ValuEngine upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning.

Other research analysts have also issued research reports about the stock. Jefferies Financial Group set a $38.00 target price on shares of Prestige Consumer Healthcare and gave the stock a hold rating in a research report on Thursday, August 2nd. DA Davidson increased their target price on shares of Prestige Consumer Healthcare to $38.00 and gave the stock a neutral rating in a research report on Monday, November 5th. Finally, Zacks Investment Research lowered shares of Prestige Consumer Healthcare from a hold rating to a strong sell rating in a research report on Tuesday, July 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $72.40.

Shares of NYSE:PBH traded down $1.12 on Wednesday, reaching $39.81. 391,072 shares of the company’s stock were exchanged, compared to its average volume of 617,804. Prestige Consumer Healthcare has a twelve month low of $27.84 and a twelve month high of $48.24. The firm has a market cap of $2.14 billion, a PE ratio of 15.43, a PEG ratio of 2.05 and a beta of 1.04. The company has a quick ratio of 1.38, a current ratio of 2.15 and a debt-to-equity ratio of 1.59.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, November 1st. The company reported $0.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.02. Prestige Consumer Healthcare had a net margin of 33.38% and a return on equity of 11.82%. The firm had revenue of $239.36 million for the quarter, compared to analyst estimates of $236.28 million. During the same quarter in the prior year, the business posted $0.61 EPS. The business’s revenue was down 7.2% compared to the same quarter last year. On average, research analysts expect that Prestige Consumer Healthcare will post 2.88 EPS for the current year.

Several hedge funds have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its stake in shares of Prestige Consumer Healthcare by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 671,871 shares of the company’s stock valued at $25,457,000 after acquiring an additional 19,028 shares during the last quarter. Janus Henderson Group PLC raised its stake in shares of Prestige Consumer Healthcare by 1.7% during the third quarter. Janus Henderson Group PLC now owns 959,215 shares of the company’s stock valued at $36,345,000 after acquiring an additional 16,173 shares during the last quarter. Eagle Boston Investment Management Inc. raised its stake in shares of Prestige Consumer Healthcare by 3.6% during the third quarter. Eagle Boston Investment Management Inc. now owns 302,733 shares of the company’s stock valued at $11,470,000 after acquiring an additional 10,383 shares during the last quarter. Eagle Asset Management Inc. raised its stake in shares of Prestige Consumer Healthcare by 7.9% during the third quarter. Eagle Asset Management Inc. now owns 209,986 shares of the company’s stock valued at $7,956,000 after acquiring an additional 15,434 shares during the last quarter. Finally, Zeke Capital Advisors LLC bought a new position in shares of Prestige Consumer Healthcare during the third quarter valued at $420,000.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Further Reading: Does the discount rate affect the economy?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply